For the last three decades, Zambia has implemented a series of policies to gradually work towards Universal Health Coverage (UHC). This case study delves into the process followed by the government of Zambia in developing those policies, with the aim of supporting other countries embarking on the jo...
Almost 140,000 people die with a drug-resistant bacterial infection in Brazil every year due in large part to shortcomings in access, stewardship, and innovation for antimicrobials. Brazil’s existing Productive Development Partnerships system could be modified to reduce incentives for overselling an...
Antimicrobial resistance (AMR) poses a threat to global health security worldwide, and India carries one of the largest burdens of drug-resistant pathogens. The widespread misuse and overuse of antimicrobials is a major cause of the emergence and spread of resistant microorganisms. This study assess...
Climate change will have major ramifications for migration at every level. This brief reviews issues faced in the governance of climate-affected migration at the internal, regional, and international levels and proposes policy actions in numerous spheres of action.
HTAIn has shown a good realised return on investment of 9:1. To further increase the return on investment, India can strategically scale up HTAIn and carry out careful selection of which topics to carry out HTAs on.
Drug-resistant infections kill an estimated 23,210 Japanese citizens every year. The government of Japan is considering a program that would provide minimum guaranteed revenue to the successful developers of new antibiotics. We present the results of a modelling exercise to estimate the likely retur...
Drug-resistant infections kill an estimated 7,600 UK citizens every year. Without investment for new antimicrobials, deaths from drug-resistant infections could increase dramatically in the coming decade. We present the results of a modelling exercise to estimate the likely ROI from an expanded prog...